Data-driven, AI-enabled drug discovery is becoming a reality, reflected in the rise of ‘AI-first’ companies such as Recursion and Insilico Medicine. Traditional pharmaceutical companies are also ...

This dynamic environment has prompted the Healthcare Communications Association (HCA) Foresight Committee to develop Going Green, a new report sharing insights on six themes exploring progress towards ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval of lecanemab. This particular therapy is a monoclonal antibody treatment for use among patient populations with mild ...

Make no mistake, innovation in diabetes care is critical. Diabetes never takes a break. People with diabetes manage their condition on their own, 365 days a year – making multiple therapy decisions ...

Laughter is the best medicine – isn’t that how the old saying goes? Well, in all seriousness, it turns out there is ample scientific evidence to back it up! Laughter strengthens your immune system, ...

Our cover feature (p31) this month takes a renewed look at how artificial intelligence is shaping an exciting new horizon for pharma and healthcare. It is clear that pharma must closely align with the ...

A new year brings new challenges for pharma, but just as many – if not more – opportunities. With the EMA moving (see p20) and Brexit, as ever, on the horizon, one of the most pressing questions ...

Whilst we have seen the COVID pandemic wreak havoc on care pathways across the country, it has also spurred closer and more concentrated working relationships between all factions of healthcare, with ...